IL153513A - תכשיר רוקחות המכיל שילוב של סולפוניל אוריאה כגורם נוגד סכרת ומעכב fbpase ושימוש בהם להכנת תרופות לטיפול בסכרת - Google Patents
תכשיר רוקחות המכיל שילוב של סולפוניל אוריאה כגורם נוגד סכרת ומעכב fbpase ושימוש בהם להכנת תרופות לטיפול בסכרתInfo
- Publication number
- IL153513A IL153513A IL153513A IL15351302A IL153513A IL 153513 A IL153513 A IL 153513A IL 153513 A IL153513 A IL 153513A IL 15351302 A IL15351302 A IL 15351302A IL 153513 A IL153513 A IL 153513A
- Authority
- IL
- Israel
- Prior art keywords
- medicaments
- diabetes
- manufacture
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21653100P | 2000-07-06 | 2000-07-06 | |
PCT/US2001/021557 WO2002003978A2 (en) | 2000-07-06 | 2001-07-05 | A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153513A true IL153513A (he) | 2014-07-31 |
Family
ID=22807416
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15351301A IL153513A0 (en) | 2000-07-06 | 2001-07-05 | A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES |
IL153513A IL153513A (he) | 2000-07-06 | 2002-12-18 | תכשיר רוקחות המכיל שילוב של סולפוניל אוריאה כגורם נוגד סכרת ומעכב fbpase ושימוש בהם להכנת תרופות לטיפול בסכרת |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15351301A IL153513A0 (en) | 2000-07-06 | 2001-07-05 | A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1372660A2 (he) |
JP (1) | JP2004508297A (he) |
KR (1) | KR100854851B1 (he) |
CN (2) | CN100396283C (he) |
AU (2) | AU2001273271B2 (he) |
BR (1) | BR0112212A (he) |
CA (1) | CA2412142A1 (he) |
CZ (1) | CZ20035A3 (he) |
HU (1) | HUP0301830A3 (he) |
IL (2) | IL153513A0 (he) |
MX (1) | MXPA02012713A (he) |
NO (1) | NO20030034L (he) |
NZ (1) | NZ523227A (he) |
PL (1) | PL365779A1 (he) |
RU (1) | RU2328308C2 (he) |
SK (1) | SK62003A3 (he) |
WO (1) | WO2002003978A2 (he) |
ZA (1) | ZA200300044B (he) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6452098A (en) | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel purine inhibitors of fructose-1,6-bisphosphatase |
JP2002524463A (ja) | 1998-09-09 | 2002-08-06 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−1,6−ビスホスファターゼの新規な芳香族インヒビター |
AU2001245532B2 (en) | 2000-03-08 | 2005-08-11 | Metabasis Therapeutics, Inc. | Novel aryl fructose-1,6-bisphosphatase inhibitors |
NZ532427A (en) | 2001-09-24 | 2008-07-31 | Imp Innovations Ltd | Modification of feeding behavior using PYY (peptide YY) and its agonists such as NPY (neuropeptide Y) |
AU2003201998C1 (en) | 2002-01-10 | 2012-10-25 | Imperial Innovations Limited | Modification of feeding behavior |
GB0300571D0 (en) | 2003-01-10 | 2003-02-12 | Imp College Innovations Ltd | Modification of feeding behaviour |
EA013249B1 (ru) | 2003-12-26 | 2010-04-30 | Киова Хакко Кирин Ко., Лтд. | Производные тиазола |
US20070225259A1 (en) * | 2004-08-18 | 2007-09-27 | Qun Dang | Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase |
TW200633720A (en) * | 2004-12-13 | 2006-10-01 | Sankyo Co | Medicinal composition for diabetic |
TW200738245A (en) * | 2005-08-22 | 2007-10-16 | Sankyo Co | Pharmaceutical composition containing FBPase inhibitor |
WO2007129522A1 (ja) * | 2006-04-10 | 2007-11-15 | Daiichi Sankyo Company, Limited | 乾式製造法製剤 |
US20100222304A1 (en) | 2006-11-02 | 2010-09-02 | Lillian W Chiang | Methods of Treating Neuropathic Pain by Modulation of Glycogenolysis or Glycolysis |
TWI428346B (zh) | 2006-12-13 | 2014-03-01 | Imp Innovations Ltd | 新穎化合物及其等對進食行為影響 |
CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
UY35065A (es) * | 2012-10-08 | 2014-05-30 | Lg Life Sciences Ltd | Fármaco combinado que comprende gemigliptina y metformina y método para su preparación |
CN104788350A (zh) * | 2014-01-22 | 2015-07-22 | 天津大学 | 一种通过快速冷却结晶法获得甲糖宁药用优势晶型的方法 |
CN106831437B (zh) * | 2016-02-03 | 2019-06-21 | 华中师范大学 | 含硝基乙烯基的酯类化合物及其制备方法和应用 |
CN114907285B (zh) * | 2021-02-10 | 2023-09-22 | 华中师范大学 | 酰化糖精类化合物及其制备方法和应用、降血糖药物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2008325A1 (en) * | 1989-01-24 | 1990-07-24 | Harry E. Gruber | Method and compounds for aica riboside delivery and for lowering blood glucose |
AU6452098A (en) * | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel purine inhibitors of fructose-1,6-bisphosphatase |
PT970095E (pt) * | 1997-03-07 | 2004-03-31 | Metabasis Therapeutics Inc | Novos inibidores benzimidazole de frutose-1,6-bisfosfatase |
AU6691798A (en) * | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
AU3087099A (en) * | 1998-03-16 | 1999-10-11 | Ontogen Corporation | Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase) |
JP2002524463A (ja) * | 1998-09-09 | 2002-08-06 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−1,6−ビスホスファターゼの新規な芳香族インヒビター |
CN101164618A (zh) * | 1998-12-24 | 2008-04-23 | 症变治疗公司 | 治疗糖尿病的fbp酶抑制剂与胰岛素致敏剂的组合 |
PT1248604E (pt) * | 2000-01-21 | 2007-01-31 | Novartis Ag | Associações compreendendo inibidor de dipeptidilpeptidase-iv |
GB0015627D0 (en) * | 2000-06-26 | 2000-08-16 | Rademacher Group Limited | Phosphoglycan messengers and their medical uses |
-
2001
- 2001-07-05 BR BR0112212-6A patent/BR0112212A/pt not_active IP Right Cessation
- 2001-07-05 CN CNB018149243A patent/CN100396283C/zh not_active Expired - Fee Related
- 2001-07-05 NZ NZ523227A patent/NZ523227A/en not_active IP Right Cessation
- 2001-07-05 HU HU0301830A patent/HUP0301830A3/hu unknown
- 2001-07-05 AU AU2001273271A patent/AU2001273271B2/en not_active Ceased
- 2001-07-05 PL PL01365779A patent/PL365779A1/xx unknown
- 2001-07-05 MX MXPA02012713A patent/MXPA02012713A/es not_active Application Discontinuation
- 2001-07-05 IL IL15351301A patent/IL153513A0/xx unknown
- 2001-07-05 CA CA002412142A patent/CA2412142A1/en not_active Abandoned
- 2001-07-05 JP JP2002508433A patent/JP2004508297A/ja active Pending
- 2001-07-05 RU RU2003103436/15A patent/RU2328308C2/ru not_active IP Right Cessation
- 2001-07-05 EP EP01952530A patent/EP1372660A2/en not_active Withdrawn
- 2001-07-05 SK SK6-2003A patent/SK62003A3/sk unknown
- 2001-07-05 CN CNA200810098112XA patent/CN101301294A/zh active Pending
- 2001-07-05 AU AU7327101A patent/AU7327101A/xx active Pending
- 2001-07-05 CZ CZ20035A patent/CZ20035A3/cs unknown
- 2001-07-05 WO PCT/US2001/021557 patent/WO2002003978A2/en active IP Right Grant
- 2001-07-05 KR KR1020037000126A patent/KR100854851B1/ko active IP Right Grant
-
2002
- 2002-12-18 IL IL153513A patent/IL153513A/he not_active IP Right Cessation
-
2003
- 2003-01-02 ZA ZA200300044A patent/ZA200300044B/en unknown
- 2003-01-03 NO NO20030034A patent/NO20030034L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN100396283C (zh) | 2008-06-25 |
CN1599612A (zh) | 2005-03-23 |
HUP0301830A2 (hu) | 2003-11-28 |
CA2412142A1 (en) | 2002-01-17 |
BR0112212A (pt) | 2003-12-30 |
IL153513A0 (en) | 2003-07-06 |
NO20030034D0 (no) | 2003-01-03 |
ZA200300044B (en) | 2004-05-06 |
KR20030031952A (ko) | 2003-04-23 |
RU2328308C2 (ru) | 2008-07-10 |
AU7327101A (en) | 2002-01-21 |
CZ20035A3 (cs) | 2003-05-14 |
NO20030034L (no) | 2003-03-05 |
PL365779A1 (en) | 2005-01-10 |
WO2002003978A2 (en) | 2002-01-17 |
WO2002003978A3 (en) | 2003-10-16 |
NZ523227A (en) | 2005-04-29 |
AU2001273271B2 (en) | 2006-01-05 |
JP2004508297A (ja) | 2004-03-18 |
SK62003A3 (en) | 2003-09-11 |
HUP0301830A3 (en) | 2007-10-29 |
EP1372660A2 (en) | 2004-01-02 |
MXPA02012713A (es) | 2004-09-10 |
KR100854851B1 (ko) | 2008-08-27 |
CN101301294A (zh) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL153513A (he) | תכשיר רוקחות המכיל שילוב של סולפוניל אוריאה כגורם נוגד סכרת ומעכב fbpase ושימוש בהם להכנת תרופות לטיפול בסכרת | |
HUP0300642A3 (en) | Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent | |
HUP0301194A3 (en) | Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus | |
HUP0301452A3 (en) | Pharmaceutical composition containing photochemotherapeutic agent and mucoadhesive agent and its use | |
IL148168A0 (en) | Pharmaceutical composition of nateglinide and another antidiabetic agent | |
IL163278A (he) | פורמולציות הכוללות תרכובות glp–1 ושימוש בהם להכנת תרופות | |
IL220888A0 (en) | 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
EP1600168A3 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder | |
HK1078851A1 (en) | 2-Indolinone-monoethanesulphonate and the use thereof in preparing a pharmaceutical composition | |
HUS1400025I1 (hu) | Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek | |
IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
HUP0302550A3 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them | |
IL203923A (en) | Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds | |
HUP0104579A3 (en) | Glp-1 analogues, pharmaceutical compositions comprising thereof and their use | |
HK1069974A1 (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-II diabetes mellitus | |
HUP0104574A3 (en) | Analogues of glp-1, pharmaceutical compositions comprising thereof and their use | |
HUP0400037A2 (hu) | Obstruktív légúti megbetegedések kezelésére szolgáló PDE4 inhibitor és antikolinerg hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény | |
IL149139A0 (en) | Pharmaceutical compositions containing metformin and glyburide | |
IL150383A0 (en) | Glyburide and pharmaceutical compositions containing the same | |
IL156577A0 (en) | Selective cathepsin s inhibitors and pharmaceutical compositions containing the same | |
HUP0402318A3 (en) | Pharmaceutical composition comprising cyclosporin and use thereof | |
IL167406A (en) | Lipophilic diesters of chelating agent and uses thereof for the preparation of medicaments for the inhibition of protease activity | |
IL155853A0 (en) | Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases | |
HUP0402061A3 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, cox-2 inhibitor and a taxol | |
IL162101A (en) | Crystalline form of a ribofuranosyluronamide derivative, pharmaceutical compositions comprising it, processes for its preparation and use thereof in the preparation of medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |